Total Payments
$5,469
2024 Payments
$2,021
Companies
28
Transactions
239
Medicare Patients
570
Medicare Billing
$144,419
Payment Breakdown by Category
Food & Beverage$5,442 (99.5%)
Education$26.73 (0.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,442 | 238 | 99.5% |
| Education | $26.73 | 1 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,798 | 78 | $0 (2024) |
| Lilly USA, LLC | $652.53 | 34 | $0 (2024) |
| PFIZER INC. | $574.78 | 29 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $306.54 | 16 | $0 (2024) |
| Lundbeck LLC | $296.08 | 12 | $0 (2024) |
| Eisai Inc. | $271.77 | 8 | $0 (2024) |
| UCB, Inc. | $249.25 | 10 | $0 (2024) |
| Neurelis, Inc. | $211.47 | 11 | $0 (2024) |
| Biohaven Pharmaceutical Holding Company Ltd. | $127.00 | 2 | $0 (2022) |
| Allergan, Inc. | $119.00 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,021 | 93 | ABBVIE INC. ($458.89) |
| 2023 | $2,430 | 123 | ABBVIE INC. ($909.48) |
| 2022 | $796.06 | 21 | ABBVIE INC. ($308.04) |
| 2021 | $221.52 | 2 | AbbVie Inc. ($121.52) |
All Payment Transactions
239 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | PFIZER INC. | ZAVZPRET (Drug) | Food and Beverage | In-kind items and services | $21.02 | General |
| Category: PAIN | ||||||
| 12/20/2024 | PFIZER INC. | ZAVZPRET (Drug) | Food and Beverage | In-kind items and services | $1.90 | General |
| Category: PAIN | ||||||
| 12/19/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $23.04 | General |
| Category: Neuroscience | ||||||
| 12/18/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $29.28 | General |
| Category: Neurology | ||||||
| 12/13/2024 | UCB, Inc. | Zilbrysq (Drug) | Food and Beverage | In-kind items and services | $31.56 | General |
| Category: Neurology | ||||||
| 12/05/2024 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $11.16 | General |
| Category: Neuroscience | ||||||
| 12/04/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $24.82 | General |
| 12/03/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $24.86 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/13/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $32.50 | General |
| Category: Neurology | ||||||
| 08/13/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $2.36 | General |
| Category: Neurology | ||||||
| 08/07/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $29.60 | General |
| Category: NEUROLOGY | ||||||
| 07/24/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: Neuroscience | ||||||
| 07/23/2024 | ABBVIE INC. | QULIPTA (Drug), BOTOX | Food and Beverage | In-kind items and services | $25.69 | General |
| Category: NEUROSCIENCE | ||||||
| 07/20/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $22.03 | General |
| Category: NEUROLOGY | ||||||
| 07/17/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $34.21 | General |
| Category: Neurology | ||||||
| 07/16/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $6.95 | General |
| Category: NEUROLOGY | ||||||
| 07/12/2024 | ABBVIE INC. | QULIPTA (Drug), BOTOX | Food and Beverage | In-kind items and services | $29.33 | General |
| Category: NEUROSCIENCE | ||||||
| 07/11/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $20.16 | General |
| Category: Neurology | ||||||
| 07/10/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $22.63 | General |
| Category: NEUROLOGY | ||||||
| 07/09/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $8.06 | General |
| Category: NEUROSCIENCE | ||||||
| 06/28/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $27.06 | General |
| Category: PAIN | ||||||
| 06/27/2024 | Lilly USA, LLC | AMYVID (Drug) | Food and Beverage | In-kind items and services | $11.38 | General |
| Category: Neuroscience | ||||||
| 06/20/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: Neurology | ||||||
| 06/19/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | Cash or cash equivalent | $123.91 | General |
| Category: Neurology | ||||||
| 06/19/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $26.56 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 524 | 11,828 | $351,127 | $137,496 |
| 2022 | 2 | 46 | 57 | $17,333 | $6,923 |
Total Patients
570
Total Services
11,885
Medicare Billing
$144,419
Procedure Codes
8
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 28 | 11,200 | $134,400 | $55,481 | 41.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 174 | 174 | $79,170 | $27,822 | 35.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 147 | 228 | $60,876 | $24,427 | 40.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 113 | 134 | $50,116 | $19,862 | 39.6% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2023 | 29 | 57 | $19,950 | $7,234 | 36.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 33 | 35 | $6,615 | $2,671 | 40.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 35 | 35 | $15,925 | $6,319 | 39.7% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2022 | 11 | 22 | $1,408 | $603.90 | 42.9% |
About Dr. Riya Luhar, D.O
Dr. Riya Luhar, D.O is a Neurology healthcare provider based in La Jolla, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/04/2017. The National Provider Identifier (NPI) number assigned to this provider is 1235665662.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Riya Luhar, D.O has received a total of $5,469 in payments from pharmaceutical and medical device companies, with $2,021 received in 2024. These payments were reported across 239 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($5,442).
As a Medicare-enrolled provider, Luhar has provided services to 570 Medicare beneficiaries, totaling 11,885 services with total Medicare billing of $144,419. Data is available for 2 years (2022–2023), covering 8 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location La Jolla, CA
- Active Since 05/04/2017
- Last Updated 01/02/2026
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1235665662
Products in Payments
- QULIPTA (Drug) $765.90
- BOTOX (Biological) $685.50
- NURTEC ODT (Drug) $589.82
- UBRELVY (Drug) $465.53
- EMGALITY (Drug) $431.72
- VYEPTI (Biological) $296.08
- Leqembi (Drug) $271.77
- VALTOCO (Drug) $211.47
- AJOVY (Biological) $207.68
- AMYVID (Drug) $178.95
- Fintepla (Drug) $156.70
- VYVGART HYTRULO (Drug) $116.31
- NUEDEXTA (Drug) $101.39
- Trudhesa (Drug) $89.89
- COMIRNATY (Biological) $70.60
- Zilbrysq (Drug) $65.99
- TYSABRI (Biological) $63.54
- Austedo XR (Drug) $52.52
- ZEMBRACE SYMTOUCH (Drug) $49.54
- AUSTEDO (Drug) $46.34
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in La Jolla
Charles Smith, M.d, M.D
Neurology — Payments: $590,505
Neurology $590,505
Dr. Jody Corey-Bloom, Md, Phd, MD, PHD
Neurology — Payments: $452,305
Neurology $452,305
Dr. Jay Rosenberg, M.d, M.D
Neurology — Payments: $216,627
Neurology $216,627
Dr. Christy Jackson, M.d, M.D
Neurology — Payments: $213,127
Neurology $213,127
Dr. Emily Engel, M.d, M.D
Neurology — Payments: $151,871
Neurology $151,871
Dr. Dee Silver, Md, MD
Neurology — Payments: $103,830
Neurology $103,830